Mettler-Toledo International, Inc.

MTD Healthcare Diagnostics & Research

Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024.

Revenue
+6.27%
EPS
+16.2%
Free cash flow
+33.0%
Total debt
−8.42%

Quarter to September 2026, against a year earlier

1,749.08 70.00 +4.17%
Market cap
$33.6B
P/E
37.7×
Fwd P/E
36.1×
Dividend yield
—
F-score
5/9
Altman Z
10.23
Beneish M
−2.44
Dividend safety
n/a

Mettler-Toledo International, Inc. 10-Q filed May 8, 2026

Fiscal Q1 2026 · Period ended Mar 31, 2026 · Filed · accepted 11:42 AM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Nov 7, 2025: 22 added · 24 removed · 38 modified; 6 with only figures updated

  1. Modified · General

    Our interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Operating results for the three and nine months ended September 30March 31, 20252026 are not necessarily indicative of the results to be expected for the full year ending December 31, 20252026.